ASK REDCHAT ANYTHING ABOUT FRACTYL HEALTH INC.
Fractyl Health Inc. (NASDAQ: GUTS)
Listen to this Section
$0.76
-0.0379
(
-4.74% )
723.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| RevitaDetailsObesity, Type 2 diabetes |
Phase 1 |
Market Data
|
| Open |
$0.76 |
| Previous Close |
$0.80 |
| Volume |
723.1K |
| Market Cap |
$122.95M |
| Day Range |
$0.75 - $0.82 |
| 52 Week Range |
$0.38 - $2.45 |
| Shares Outstanding |
158.65M |
| Change % |
-4.74% |
| Net Change |
▼ -0.0379 |
| Insider Ownership |
-0.05% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | |
| IPO Year | 2024 |
| Country | United States |
| Underwriter | BofA Securities, Morgan Stanley, Evercore ISI, more |
Insider Ownership Transactions
Total Amount Purchased:
2,350,947.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-02-05 |
Sale |
-45000.00 |
SCHULMAN AMY W |
| 2024-02-05 |
Sale |
-45000.00 |
Will Allan R |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
1 |
Nov 14, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
66 |
Nov 12, 2025 |
| 8-k |
8K-related |
12 |
Nov 12, 2025 |
| 8-k |
8K-related |
10 |
Oct 03, 2025 |
| 8-k |
8K-related |
36 |
Sep 26, 2025 |
| 8-k |
8K-related |
17 |
Sep 26, 2025 |
| 3 |
Insider transactions |
2 |
Sep 04, 2025 |